Andrews Ronald Asbury is Former CEO of Oncocyte Corporation.
Person profile
Latest filings (excl ownership)
No filings
Recent insider trades
Date | Company | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
15 Apr 24 | PRPO Precipio | Common Stock | Grant | Acquire A | No | No | 6.66 | 3,153 | 21.00 k | 7,461 |
24 Oct 23 | PRPO Precipio | Common Stock | Grant | Acquire A | No | No | 0 | 4,005 | 0.00 | 4,308 |
12 Sep 23 | PRPO Precipio | Common Stock | Grant | Acquire A | No | No | 0 | 6,060 | 0.00 | 6,060 |
6 Jan 23 | PRPO Precipio | Stock Option Common Stock | Grant | Acquire A | No | No | 0.62 | 30,000 | 18.60 k | 30,000 |
7 Dec 22 | OCX Oncocyte | Option to Purchase Common Stock Common Stock | Grant | Acquire A | No | No | 0.4644 | 50,000 | 23.22 k | 50,000 |
1 Dec 22 | OCX Oncocyte | Common Stock, no par value | Option exercise | Acquire M | No | No | 0 | 250,000 | 0.00 | 583,212 |
1 Dec 22 | OCX Oncocyte | RSU Common Stock | Option exercise | Dispose M | No | No | 0 | 250,000 | 0.00 | 0 |
1 Dec 22 | OCX Oncocyte | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 250,000 | 0.00 | 250,000 |
1 Dec 22 | OCX Oncocyte | RSU Common Stock | Sale back to company | Dispose D | No | No | 0 | 35,000 | 0.00 | 0 |
1 Dec 22 | OCX Oncocyte | Option to Purchase Common Stock Common Stock | Sale back to company | Dispose D | No | No | 1.15 | 93,750 | 107.81 k | 281,250 |